GILEAD SCIENCES, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| MARTIN JOHN C | — | Award / Grant | 15,505 | — | — | 2,901,012 | Feb 6, 2019 |
| Alton Gregg H | EVP,Corporate &Medical Affairs | Tax Withholding | 5,861 | $68.75 | $402,944 | 57,716 | Feb 6, 2019 |
| Pletcher Brett A | EVP, Gen Counsel & Corp Sec | Tax Withholding | 3,871 | $68.75 | $266,131 | 32,684 | Feb 6, 2019 |
| Washington Robin L | EVP, CFO | Award / Grant | 8,270 | — | — | 38,743 | Feb 6, 2019 |
| McHutchison John G | Chief Scientific Off/HeadR&D | Award / Grant | 8,323 | — | — | 35,177 | Feb 6, 2019 |
| BARTON JACQUELINE K | — | Option Exercise | 480 | — | — | 13,740 | Jan 31, 2019 |
| McHutchison John G | Chief Scientific Off/HeadR&D | Tax Withholding | 2,988 | $65.12 | $194,579 | 26,854 | Dec 17, 2018 |
| MARTIN JOHN C | — | Sale | 200 | $72.67 | $14,534 | 2,877,762 | Dec 3, 2018 |
| MILLIGAN JOHN F | President and CEO | Option Exercise | 280,000 | $23.60 | $6,608,000 | 1,574,306 | Nov 27, 2018 |
| McHutchison John G | Chief Scientific Off/HeadR&D | Tax Withholding | 664 | $71.18 | $47,264 | 23,707 | Nov 10, 2018 |
| MARTIN JOHN C | — | Sale | 8,000 | $68.61 | $548,880 | 3,059,762 | Nov 1, 2018 |
| MARTIN JOHN C | — | Sale | 16,670 | $78.34 | $1,305,928 | 3,017,762 | Oct 1, 2018 |
| MARTIN JOHN C | — | Option Exercise | 50,000 | $23.60 | $1,180,000 | 3,067,762 | Sep 4, 2018 |
| Pletcher Brett A | EVP, Gen Counsel & Corp Sec | Award / Grant | 94 | $63.61 | $5,979 | 20,706 | Aug 15, 2018 |
| Pletcher Brett A | EVP, Gen Counsel & Corp Sec | Tax Withholding | 489 | $76.73 | $37,521 | 20,612 | Aug 10, 2018 |
| MARTIN JOHN C | — | Sale | 50,000 | $77.85 | $3,892,500 | 3,017,762 | Aug 1, 2018 |
| Pletcher Brett A | EVP, Gen Counsel & Corp Sec | Option Exercise | 2,000 | — | — | 20,941 | Jul 31, 2018 |
| MARTIN JOHN C | — | Sale | 300 | $71.36 | $21,408 | 3,017,762 | Jul 2, 2018 |
| MARTIN JOHN C | — | Option Exercise | 50,000 | $23.60 | $1,180,000 | 3,067,762 | Jun 1, 2018 |
| Cogan John Francis | — | Option Exercise | 2,241 | — | — | 54,860 | May 8, 2018 |
| WILSON GAYLE E | — | Option Exercise | 2,241 | — | — | 124,499 | May 8, 2018 |
| WOLD OLSEN PER | — | Option Exercise | 2,241 | — | — | 95,571 | May 8, 2018 |
| MILLIGAN JOHN F | President and CEO | Option Exercise | 80,000 | $27.07 | $2,165,600 | 1,294,306 | May 4, 2018 |
| Cogan John Francis | — | Sale | 5,836 | $65.09 | $379,865 | 52,619 | May 4, 2018 |
| MARTIN JOHN C | — | Option Exercise | 50,000 | $23.60 | $1,180,000 | 3,067,762 | May 1, 2018 |
| Cogan John Francis | — | Option Exercise | 5,833 | $26.62 | $155,274 | 58,452 | Apr 27, 2018 |
| Cogan John Francis | — | Option Exercise | 5,833 | $26.62 | $155,274 | 58,452 | Apr 20, 2018 |
| Cogan John Francis | — | Sale | 5,833 | $75.56 | $440,741 | 52,619 | Apr 13, 2018 |
| Cogan John Francis | — | Sale | 5,833 | $74.47 | $434,384 | 52,619 | Apr 6, 2018 |
| Cogan John Francis | — | Option Exercise | 5,833 | $26.62 | $155,274 | 58,452 | Apr 2, 2018 |
| MARTIN JOHN C | — | Sale | 700 | $74.98 | $52,486 | 3,017,762 | Apr 2, 2018 |
| Cogan John Francis | — | Sale | 5,833 | $75.02 | $437,592 | 52,619 | Mar 23, 2018 |
| Cogan John Francis | — | Option Exercise | 5,833 | $26.62 | $155,274 | 58,452 | Mar 16, 2018 |
| Cogan John Francis | — | Sale | 5,833 | $80.93 | $472,065 | 52,619 | Mar 12, 2018 |
| MARTIN JOHN C | Executive Chairman | Sale | 16,902 | $77.84 | $1,315,652 | 3,050,860 | Mar 1, 2018 |
| MOORE NICHOLAS G | — | Option Exercise | 178 | — | — | 12,233 | Mar 1, 2018 |
| Alton Gregg H | EVP,Corporate &Medical Affairs | Option Exercise | 17,250 | $40.56 | $699,660 | 69,426 | Mar 1, 2018 |
| Washington Robin L | EVP, CFO | Sale | 5,000 | $80.31 | $401,550 | 105,405 | Feb 28, 2018 |
| Meyers James R | EVP Worldwide Commercial Ops | Award / Grant | 4,846 | — | — | 7,782 | Feb 21, 2018 |
| YOUNG KEVIN | Chief Operating Officer | Award / Grant | 340 | $62.35 | $21,199 | 16,152 | Feb 21, 2018 |
| MARTIN JOHN C | Executive Chairman | Award / Grant | 340 | $62.35 | $21,199 | 2,997,106 | Feb 21, 2018 |
| BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Award / Grant | 340 | $62.35 | $21,199 | 12,793 | Feb 21, 2018 |
| Alton Gregg H | EVP,Corporate &Medical Affairs | Sale | 14,435 | $81.54 | $1,177,030 | — | Feb 20, 2018 |
| Alton Gregg H | EVP,Corporate &Medical Affairs | Tax Withholding | 5,894 | $80.69 | $475,587 | 52,176 | Feb 15, 2018 |
| MILLIGAN JOHN F | President and CEO | Award / Grant | 7,709 | — | — | 1,222,315 | Feb 15, 2018 |
| Washington Robin L | EVP, CFO | Award / Grant | 14,654 | — | — | 24,596 | Feb 15, 2018 |
| YOUNG KEVIN | Chief Operating Officer | Option Exercise | 908 | — | — | 16,237 | Feb 10, 2018 |
| WILSON GAYLE E | — | Sale | 60,000 | $77.92 | $4,675,200 | 122,258 | Feb 9, 2018 |
| MARTIN JOHN C | Executive Chairman | Sale | 19,277 | $83.35 | $1,606,738 | 3,027,489 | Feb 1, 2018 |
| Alton Gregg H | EVP,Corporate &Medical Affairs | Option Exercise | 17,250 | $40.56 | $699,660 | 62,738 | Feb 1, 2018 |